PharmaBoardroom

Swissmedic New Drug Approvals 2020

Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in…

US FDA Drug Approvals 2020

In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in 2019, across a range of therapeutic…

Jacques Marbehant – Senior Vice President, Head of Global…

Belgian champion UCB's global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufacturing and supply chain…

Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics

Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology…

Henry Suárez – President, ARAPF, Dominican Republic

The Association of Representatives, Agents and Pharmaceutical Producers (ARAPF), represents 65 companies in the Dominican Republic, including big…

Gideon Ho – Co-Founder & CEO, HistoIndex

Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their proprietary technology to provide the…

Barış Erdoğan – CEO, Clinerion

Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences industry. CEO Barış Erdoğan…

Maria T Millan – President & CEO, California Institute…

Dr Maria T. Millan, president and CEO of the California Institute for Regenerative Medicine (CIRM), shares the Institute’s mission to advance basic…

Vaccines: An Expanded R&D Playbook

The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox in 1976 by injecting them with…

Pius Zängerle – Director, curafutura, Switzerland

Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique Swiss health insurance ecosystem and…

5 European Rare Disease Start-Ups to Watch

With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare disease landscape, highlighting key…

Reconsidering Cell & Gene Therapy Manufacturing

Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating an inflection point in the ability…

Tagged with